Evidences of this dual role include the down-regulation of MYC and HER2 by FOXP3+ Tregs, and the up-regulation of FOXP3 protein in both Tregs and tumor cells in patients with lung cancer and hepatocellular carcinoma [39–42]. This evidence concerns the gene MYC and neoplasm.